As I thought 3rd qtr would be a steady improvement and I expect 4th quarter will be even more significant. Distribution channels are being set up nicely and restocked as demand picks up with more product exposure. I expect to be impressed Feb 15 report followed by great earnings growth throughout 2022.
(2)
(0)
BioElectronics Corporation (BIEL) Stock Research Links